Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
FORA 
Forian Inc (FORA)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/17/2025: FORA (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
1 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $5
1 Year Target Price $5
| 0 | Strong Buy |
| 1 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -39.38% | Avg. Invested days 37 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 09/17/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 69.38M USD | Price to earnings Ratio - | 1Y Target Price 5 |
Price to earnings Ratio - | 1Y Target Price 5 | ||
Volume (30-day avg) 1 | Beta 1 | 52 Weeks Range 1.64 - 4.03 | Updated Date 09/17/2025 |
52 Weeks Range 1.64 - 4.03 | Updated Date 09/17/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.03 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -3.62% | Operating Margin (TTM) 0.62% |
Management Effectiveness
Return on Assets (TTM) -4.77% | Return on Equity (TTM) -3.2% |
Valuation
Trailing PE - | Forward PE 24.75 | Enterprise Value 40559434 | Price to Sales(TTM) 2.77 |
Enterprise Value 40559434 | Price to Sales(TTM) 2.77 | ||
Enterprise Value to Revenue 1.62 | Enterprise Value to EBITDA 20.05 | Shares Outstanding 31112300 | Shares Floating 7354951 |
Shares Outstanding 31112300 | Shares Floating 7354951 | ||
Percent Insiders 51.91 | Percent Institutions 13.59 |
Upturn AI SWOT
Forian Inc
Company Overview
History and Background
Forian Inc. (formerly Medical Marijuana, Inc.) was founded with a focus on the cannabis and hemp industries. It has evolved to provide data and technology solutions for these sectors, assisting businesses with analytics, compliance, and business intelligence.
Core Business Areas
- Data and Analytics: Provides data-driven insights and analytics solutions to cannabis and hemp businesses, helping them make informed decisions about market trends, customer behavior, and operational efficiency.
- Compliance and Regulatory Solutions: Offers compliance tools and services to help businesses navigate the complex regulatory landscape of the cannabis and hemp industries.
- Technology Platforms: Develops and operates technology platforms that support various aspects of the cannabis and hemp supply chain, including seed-to-sale tracking, inventory management, and point-of-sale systems.
Leadership and Structure
Information on leadership and specific organizational structure is not readily available in summary formats. Generally, a small cap company such as this would have a CEO, CFO, CTO, and VP-level functional leads in key functional areas.
Top Products and Market Share
Key Offerings
- Cannabis Analytics Platform: A data and analytics platform designed to provide cannabis businesses with insights into market trends, consumer behavior, and competitive analysis. Market share data specifically tied to this product is not readily available. Competitors include New Frontier Data, Headset, and BDSA.
- Regulatory Compliance Software: Software that helps cannabis businesses stay compliant with state and local regulations regarding cannabis production, distribution, and sales. Market share data specifically tied to this product is not readily available. Competitors include Simplifya, Greenbits (acquired by Dutchie), and Flowhub (though mostly point of sale).
Market Dynamics
Industry Overview
The cannabis industry is experiencing rapid growth and increasing legalization, driven by changing consumer attitudes and growing acceptance of cannabis for medicinal and recreational use. However, it faces regulatory challenges, market volatility, and competition.
Positioning
Forian Inc. aims to be a leading provider of data and technology solutions in the cannabis and hemp industries, helping businesses navigate the complexities of the market and optimize their operations. Their competitive advantage lies in their focus on data-driven insights and compliance solutions.
Total Addressable Market (TAM)
The global cannabis market is projected to reach hundreds of billions of dollars in the coming years. Forian Inc. is positioned to capture a portion of this market by providing data and technology solutions that help cannabis businesses thrive.
Upturn SWOT Analysis
Strengths
- Data-driven insights
- Compliance expertise
- Technology platforms
- Industry focus
- Early mover advantage
Weaknesses
- Small market capitalization
- Limited brand recognition
- Dependence on cannabis industry
- Profitability challenges
- Historical association with Medical Marijuana, Inc.
Opportunities
- Expanding cannabis legalization
- Growing demand for data and analytics
- Increasing regulatory complexity
- Partnerships and acquisitions
- International expansion
Threats
- Regulatory uncertainty
- Market volatility
- Competition from larger players
- Changing consumer preferences
- Economic downturn
Competitors and Market Share
Key Competitors
- KSHB
- NLVR
- BDSA
Competitive Landscape
Forian faces stiff competition from larger, more established players in the data and technology space, as well as niche providers specializing in cannabis compliance and analytics. Their ability to innovate and differentiate their offerings will be crucial for success.
Growth Trajectory and Initiatives
Historical Growth: Historical growth is tied to the cannabis industry expansion. More concrete info requires SEC filings.
Future Projections: Future projections are tied to cannabis industry growth and are subject to industry risk.
Recent Initiatives: Recent initiatives likely include product development and partnerships. More info required from press releases and SEC filings.
Summary
Forian is a small cap company in the cannabis data space that offers potential in a growing market, but faces challenges related to profitability, brand recognition, and competition. Its strengths lie in its data and compliance expertise, while its weaknesses stem from its size and dependence on the cannabis industry. Key areas to watch include regulatory developments, competitive dynamics, and the company's ability to execute its growth strategy.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Filings
- Market Research Reports
- Industry News
- Third Party Data Sources
Disclaimers:
The data provided is for informational purposes only and should not be considered financial advice. Market share estimates are approximate. Actual performance may vary.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Forian Inc
Exchange NASDAQ | Headquaters Newtown, PA, United States | ||
IPO Launch date 2021-03-03 | Co-Founder, CEO, President & Executive Chairman of the Board Mr. Max C. Wygod | ||
Sector Healthcare | Industry Health Information Services | Full time employees 47 | Website https://forian.com |
Full time employees 47 | Website https://forian.com | ||
Forian Inc. provides a suite of data management capabilities, and information and analytics solutions to optimize and measure operational, clinical, and financial performance for customers in the life science, healthcare, and financial services industries. It develops commercial, real world evidence (RWE), and market access solutions and proprietary data-driven insights, as well as offers data management solutions. The company's subscription and services-based solutions cover the life sciences, pharmaceutical services, healthcare payer, and provider and financial services industries. Forian Inc. was founded in 2020 and is headquartered in Newtown, Pennsylvania.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.